Future studies elucidating the local and distal targets of clock-dependent secreted proteins hold promise for identifying therapeutic targets for diverse metabolic diseases associated with dysfunction of liver and skeletal muscle, such as sarcopenia, nonalcoholic fatty liver disease, and hepatocellular carcinoma (1, 93, 94, 95). This evidence concerns the gene CLOCK and hepatocellular carcinoma.